Companion Diagnostics Market Size

1. The companion diagnostics market analysis reveals several key findings: Market Size and Growth:  Global market valued at $8.51 billion in 2023  Projected to grow from $9.38 billion in 2024 to $22.37 billion by 2032  Compound annual growth rate (CAGR) of 11.5% during forecast period Key Market Drivers:  Rising cancer prevalence increasing demand for diagnostic tests  Advances in next-generation sequencing technologies  Growing adoption of personalized medicine  Regulatory approvals for new diagnostic tests Regional Analysis:  North America dominated with 34.55% market share in 2023  Europe expected to be second-largest market  Asia Pacific projected to grow at highest CAGR through 2032 Leading Companies:  F. Hoffmann-La Roche Ltd  Agilent Technologies  Abbott  Illumina  Thermo Fisher Scientific  QIAGEN Recent Developments:  February 2024: F. Hoffmann-La Roche partnered with PathAI to develop AI-enabled pathology algorithms  November 2023: QIAGEN partnered with Element Biosciences for NGS workflows  October 2023: QIAGEN collaborated with Myriad Genetics for cancer diagnostics Report- Fortune Business Insights - Companion Diagnostics Market Size, Trends | Growth [2032] https://www.fortunebusinessinsights.com/companion-diagnostics-market-107097